Apersys
Developer of an ex vivo liver perfusion platform and associated protocols aimed at extending liver preservation time, enabling prolonged viability assessment, and restoring fatty/damaged livers for transplant and translational research. Activities span device development, physiologic simulation for organs outside the body, preclinical and early clinical translation, and regulatory engagement.
Industries
Nr. of Employees
small (1-50)
Products
Ex vivo liver perfusion platform for extended preservation and research
A modular perfusion platform engineered to recreate physiological support for human livers outside the body, enabling multi-day normothermic preservation, continuous monitoring, and application of metabolic or pharmacological interventions.
Ex vivo liver perfusion platform for extended preservation and research
A modular perfusion platform engineered to recreate physiological support for human livers outside the body, enabling multi-day normothermic preservation, continuous monitoring, and application of metabolic or pharmacological interventions.
Services
Collaborative research and clinical program support for transplantation centers
Engagements to apply perfusion platform technology and protocols in clinical or research settings to evaluate organ recovery and enable translational studies.
Collaborative research and clinical program support for transplantation centers
Engagements to apply perfusion platform technology and protocols in clinical or research settings to evaluate organ recovery and enable translational studies.
Expertise Areas
- Organ perfusion and preservation
- Normothermic machine perfusion
- Ex vivo organ viability assessment
- Translational clinical research in transplantation
Key Technologies
- Normothermic machine perfusion
- Ex vivo organ perfusion platforms
- Closed-loop metabolic control algorithms
- Real-time organ viability monitoring